Harvard Medicine Research Fraud and Cover-up: How Off-Label Profiteering Works

What's less comprehended is why drug manufacturers spend billions for re-search on off-label uses for their products and services - when the drug was submitted for approval uses that have been never satisfied using the FDA.


Off-label use allows drug organizations to have 'through the rear door' what they are able to never, and I am talking about never, get away with by going straight to the FDA for approval for a new use of a solution - what is known today as an off-label use.


You would hope that researchers wouldn't corrupt the commercial analysis of the new, or off-label, use of a drug to deal with children by covering up their consulting fees from Big Pharma. Learn further on http://www.wnct.com/story/31641598/zofran-lawsuit-plaintiffs-note-label-differences-on-canada-version-of-drug-warning-of-use-during-pregnancy by browsing our splendid site. But that's what happened.


Harvard Drug Research Fraud and Cover-up: How Off-Label Profiteering Works


Drug company money corrupts and influences research. That's confirmed.


What is less understood is why drug companies spend billions for research on off-label uses for their products - uses which were never satisfied with the FDA when the drug was submitted for approval.


Off-label use allows drug businesses to acquire 'through the back door' what they could never, and I mean never, get-away with by going straight to the FDA for approval for a new use of the solution - what's known today as an off-label use.


You'd hope that researchers wouldn't corrupt the experimentation of the new, or off-label, utilization of a drug to treat kids by covering up their consulting expenses from Big Pharma. Going To http://www.nbc4i.com/story/31641598/zofran-lawsuit-plaintiffs-note-label-differences-on-canada-version-of-drug-warning-of-use-during-pregnancy perhaps provides suggestions you can give to your mom. But that is what happened.


More crucial than what happened is just why it happened and at the bottom of this can be a bad mistake the U.S. has made in allowing the exploitation of off-label use.


The devil is in the details, therefore this is actually the story as it has unfolded.


Leading Harvard professors understanding off-label uses, the gold-mine of the drug industry, have violated National Institute of Health r-eporting requirements when more than $10,000 is received from a subject organization, according to the New York Times, 'Researchers Fail to Reveal Drug Pay' June 8, 2008. http://www.nytimes.com/2008/06/08/us/08conflict.html?em&ex=1213070400&en=9971013dfd33290a&ei=508720say20are%20sorry&st=cse isn't enough.


If Harvard does not fire them, it will be complicit in the cover-up.


Put them off-campus. Ring the bell loud and clear that regardless of how renown or exceptional, if you do not play by the principles, you can't play at all. And THEY should be forever banned by the NIH from receiving grants.


Don't get rid of the baby with the bath water. Provide these experts a chance to develop their damaged reputations, once appropriate abuse has been served. Enable them to conduct research under the direction of a responsible administrator who understands that 'veritas,' means truth, precision, honesty, and uprightness and that it is significantly more than only a slogan. Get extra info on the affiliated article directory - Click here: http://thenumbers.marketplace.org/publicradio/news/read/31836139/zofran_lawsuit_plaintiffs_note_label_differences_on_canada_version_of_drug_warning_of_use_during_pregnancy .


Onward. In the event you require to get more about http://www.wxtx.com/story/31641598/zofran-lawsuit-plaintiffs-note-label-differences-on-canada-version-of-drug-warning-of-use-during-pregnancy , we know of lots of online resources you might think about pursuing.


Richard Alexander


http://www.alexanderinjury.com.